Table 1 Carcinogenicity classifications and sources of exposures for hormones in pharmaceuticals and personal care products
From: State of the evidence 2017: an update on the connection between breast cancer and the environment
| Product | IARC | NTP | Source of exposure |
|---|---|---|---|
| Diethylstilbestrol | 1 | K | Formerly prescribed to pregnant women to sustain viable pregnancies |
| Hormone Replacement Therapy | 1 | Treatment of symptoms experienced in menopause | |
| Conjugated equine estrogens | 2A | ||
| Medroxyprogesterone acetate | |||
| Bioidentical hormones | 1 | ||
| Oral contraceptives | 1 | Contraception | |
| Infertility treatment drugs | Infertility treatment | ||
| Clomiphene citrate | 1 | ||
| Gonadotropins | |||
| Hormones in personal care products | 1 | Use of placental extracts in personal care products, especially products marketed to women of color |
